Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-440-3 | CAS number: 778583-04-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd., Wolferstrasse 4, 4414 Füllinsdorf / Switzerland
- Age at study initiation: 6-8 weeks
- Weight at study initiation: 296 - 397 g
- Housing: Individually in Makrolon type-3 cages with standard softwood bedding
- Diet (e.g. ad libitum): Pelleted standard Nafag Ecosan 845 25W4 guinea pig breeding/maintenance diet, ad libitum
- Water (e.g. ad libitum): Community tap water from Itingen, ad libitum.
- Acclimation period: Control and test group: 1 week; pretest animals: no acclimatation
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To: - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Concentration of test material and vehicle used at induction: - intradermal: 0.1 ml /site
A) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline B) test substance diluted to 5 % (w/w) in bidistilled water C) test substance diluted to 5 % (w/w) by emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline - epidermal: 0.3 ml test substance 50 % (w/w) in bi-distilled water
Concentration of test material and vehicle used for each challenge: - epidermal: 25 % (w/w) in bi-distilled water - Route:
- epicutaneous, semiocclusive
- Vehicle:
- water
- Concentration / amount:
- Concentration of test material and vehicle used at induction: - intradermal: 0.1 ml /site
A) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline B) test substance diluted to 5 % (w/w) in bidistilled water C) test substance diluted to 5 % (w/w) by emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline - epidermal: 0.3 ml test substance 50 % (w/w) in bi-distilled water
Concentration of test material and vehicle used for each challenge: - epidermal: 25 % (w/w) in bi-distilled water - No. of animals per dose:
- Number of animals in test group: 20 Number of animals in negative control group: 10
- Details on study design:
- RANGE FINDING TESTS:
A pretest with 6 animals (intradermal: 2 animals, epidermal: 4 animals) was conducted to identify a maximally tolerated concentration of the test article suitable for the induction phase of the main study. In addition, a suitable non-irritant concentration of the test article, by the topical route of administration, was identified for the challenge application.
All animals were sensitized with intradermal application of a 1:1 suspension of FCA/physiological saline one week before the treatments.
Intradermal injections: 1, 3, and 5% in bidistilled water
Epidermal application: 10, 15, 25, 50% in bidistilled water
Reactions were evaluated 24h (intradermal injection) and 24 and 48h (epidermal application) after beginning of the treatment.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3 pairs of intradermal application with FCA, test item, and test item + FCA; 1 epicutaneous application with test item
- Exposure period: epicutaneous application: 48h
- Site: scapular region
- Frequency of applications: day 1: intradermal application; day 8: epicutaneous application
- Test item concentration: intradermal application: 5%; epicutaneous application: 50%
B. CHALLENGE EXPOSURE
- No. of exposures:
- Day(s) of challenge: on day 22
- Exposure period: approximately 24h
- Site: left and right flank
- Concentration: 25% (highest non-irritating concentration)
- Evaluation (hr after challenge): 24 and 48h after chellenge
OTHER:
- The following observations and data were recorded during the test and observation period: Viability/Mortality, Clinical Signs (local/systemic), Skin reactions, Body Weights.
Records were maintained of all additional and standard observations. - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde, 2- mercaptobenzothiazole
- Positive control results:
- ALPHA-HEXYLCINNAMALDEHYDE
In the positive control study 65% (at 24-hour reading) and 60% (at 48-hour reading) of the animals of the test group were observed with positive skin reactions after treatment with a non-irritant test substance concentration of 15% alpha-hexylcinnamaldehyde in PEG 400.
No skin reactions were observed in the control group.
2- MERCAPTOBENZOTHIAZOLE
In this positive control study 90% (at the 24-hour reading) and 100% (at the 48-hour reading) of the animals of the test group were observed with positive skin reactions after treatment with a non-irritant test substance concentration of 50% in mineral oil.
No skin reactions were observed in the control group. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The substance applied at a concentration of 25% in bi-distilled water is considered to be a non-sensitizer.
- Executive summary:
In order to assess the cutaneous allergenic potential of the substance, the Maximization-test in accordance with OECD Guideline No. 406 and the Directive 92/69 EEC B.6 was carried out in 30 (20 test and 10 control) male albino guinea pigs.
The intradermal induction of sensitization was carried out with a 5% dilution of the test article in bi-distilled water and in an emulsion with Freund's Complete Adjuvant (FCA)/physiological saline. The epicutaneous induction of sensitization was conducted under occlusion with the test article at 50% in bi-distilled water. Two weeks after the epicutaneous induction application the challenge was completed by epicutaneous application of the test article at 25% in bi-distilled water under occlusive dressing. The animals of the control group were induced with bi-distilled water and FCA/physiological and challenged similarly as those of the test group. Cutaneous reactions, i.e erythema and eschar, as well as oedema formation were evaluated at 24 and 48 hours after removal of the dressing.
No reactions were observed 24 and 48h after the challenge period.
In this study 0% of the animals of the test and control group were observed with positive skin reactions after treatment with a non-irritant test substance concentration of 25% in bi-distilled water.
Therefore, the substance applied at a concentration of 25% in bi-distilled water is considered to be a non-sensitizer when used under the described test conditions.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In order to assess the sensitizing potential of the test substance an OECD 406 Maximization test was performed. The intradermal induction of sensitization was carried out with a 5% dilution of the test article in bi-distilled water and in an emulsion with Freund's Complete Adjuvant (FCA)/physiological saline. The epicutaneous induction of sensitization was conducted under occlusion with the test article at 50% in bi-distilled water. Two weeks after the epicutaneous induction application the challenge was completed by epicutaneous application of the test article at 25% in bi-distilled water under occlusive dressing. The animals of the control group were induced with bi-distilled water and FCA/physiological and challenged similarly as those of the test group.
No reactions were observed 24 hours and 48 hours after the challenge period.
In this study 0% of the animals of the test- and control group were observed with positive skin reactions after treatment with a non-irritant test substance concentration of 25% in bidistilled water.
Migrated from Short description of key information:
In order to assess the cutaneous allergenic potential of the substance, the Maximization-test in accordance with OECD Guideline No. 406 and the Directive 92/69 EEC B.6 was carried out in 30 (20 test and 10 control) male albino guinea pigs. The registration substance is considered to be a non-skin sensitizer under the conditions of this test.
Justification for selection of skin sensitisation endpoint:
The selected study was performed under GLP and in accordance with OECD TG 406 (Maximization-test ). No other studies are available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the result of the skin sensitization study according to Magnuson & Kligman, the registration substance is considered to be a non-sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1